Elanix Biotechnologies AG (FRA:ELN) EV-to-Revenue : 77.55 (As of May. 29, 2024)

Elanix Biotechnologies AG EV-to-Revenue Chart

Elanix Biotechnologies AG Annual Data
	Trend	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18
EV-to-Revenue		Get a 7-Day Free Trial					-	-	4,513.66	103.80	178.24

Elanix Biotechnologies AG Semi-Annual Data
	Dec08	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18
EV-to-Revenue	Get a 7-Day Free Trial															4,513.66	-	103.80	-	178.24

Competitive Comparison of Elanix Biotechnologies AG's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Elanix Biotechnologies AG's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elanix Biotechnologies AG's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elanix Biotechnologies AG's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Elanix Biotechnologies AG's EV-to-Revenue falls into.

Elanix Biotechnologies AG EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Elanix Biotechnologies AG's EV-to-Revenue for today is calculated as:

Elanix Biotechnologies AG's current Enterprise Value is €4.81 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Elanix Biotechnologies AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2018 was €0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elanix Biotechnologies AG  (FRA:ELN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Elanix Biotechnologies AG's PS Ratiofor today is calculated as:

Elanix Biotechnologies AG's share price for today is €0.053.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2018 was €0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elanix Biotechnologies AG EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Elanix Biotechnologies AG's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Elanix Biotechnologies AG (FRA:ELN) Business Description